Study of erectile dysfunction in patients of type 2 diabetes mellitus and its association with cardiovascular risk
Keywords:T2 DM, ED, ASCVD
Background: Diabetes is a chronic metabolic disorder that is characterized by high level of blood glucose levels, which over a period of time can lead to micro-vascular or macro-vascular complications. Erectile dysfunction (ED) is common not much discussed and distressing complication of diabetes. ED in type 2 may be independent marker of coronary artery disease (CAD). Aim and objectives were to assess the ED in subject of type 2 diabetes mellitus (DM). Assessment of correlation of ED with CAD.
Methods: The present cross-sectional study consisted total 180 diabetic patients. On basis of international index of erectile function (IIEF) questionnaire ED patients were assessed.
Result: Out of 180 diabetic patients 36.11% had varying degree of ED. Out of 65 ED patients, maximum frequency of moderate ED (47.69%) was found then severe ED (32.30%), mild to moderate ED (12.30%) and mild ED (7.69%). Most of the patients were in the age group of 40-50 years 35 (53.84%), 50-60 years 22 (33.4%), <40 years (9.23%) and 60-70 years 2 (3.07%) showed ED. Fasting blood sugar and postprandial blood sugar showed significant (p<0.05) relation with ED. HbA1c show an insignificant correlation (p>0.05) with ED. In patient with ED was having more value of atherosclerotic cardiovascular disease (ASCVD) (9.11±4.84) than patient without ED (8.82±5.72). There was no significant (p>0.05) difference in term of ASCVD risk score in ED patient’s ED and without ED patients.
Conclusions: Poor glycemic control was a strongest risk factor for ED.
Ibrahim A, Ali M, Kiernan TJ, Stack AG. Erectile Dysfunction and Ischaemic Heart Disease. Eur Cardiol Review. 2018;13(2):98-103.
Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003;89:251-3.
Meller SM, Stilp E, Walker CN, Mena-Hurtado C. The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy. J Invasive Cardiol. 2013;25:313-9.
McCulloch DK, Campbell IW, Wu FC. The prevalence of diabetic impotence. Diabetologia. 1980;18(4):279-83.
Sasaki H, Yamasaki H, Ogawa K. Prevalence and risk factors for erectile dysfunction in Japanese diabetics. Diabetes Res Clin Pract. 2005;70(1):81-9.
Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med. 2009;6(5):1232-47.
Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012;142(1):S8-21.
De Berardis G, Pellegrini F, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S et al. Quality of Care and Outcomes in Type 2 Diabetes Study Group. Identifying patients with type 2 diabetes with a higher likelihood of erectile dysfunction: the role of the interaction between clinical and psychological factors. J Urol. 2003;169(4):1422-8.
Seid A, Gerensea H, Tarko S. Prevalence and determinants of erectile dysfunction among diabetic patients attending in hospitals of central and north western zone of Tigray, northern Ethiopia: a cross-sectional study. BMC Endocr Disord. 2017;17-16.
Jackson G, Betteridge J, Dean J, Eardley I, Hall R. A systematic approach to erectile dysfunction in the cardiovascular patient: A consensus statement update 2002. Int J Clin Pract. 2002;56:631.
Roth A, Kalter-Leibovici O, Kerbis Y, Tenenbaum Koren E, Chen J, Sobol T. Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension or both diseases: A community survey among 1,412 Israeli men. Clin Cadiol. 2003;26:25-30.